TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141 | -99.9% | 3,752 | +44.8% | 0.00% | -33.3% |
| Q4 2017 | $271,000 | -52.1% | 2,592 | -48.4% | 0.00% | -40.0% |
| Q3 2017 | $566,000 | -34.5% | 5,026 | -34.8% | 0.01% | -37.5% |
| Q2 2017 | $864,000 | -6.4% | 7,709 | -2.6% | 0.01% | 0.0% |
| Q1 2017 | $923,000 | +10.9% | 7,917 | +0.2% | 0.01% | +14.3% |
| Q4 2016 | $832,000 | -43.4% | 7,905 | -40.6% | 0.01% | -53.3% |
| Q3 2016 | $1,470,000 | +27.2% | 13,298 | +67.5% | 0.02% | +87.5% |
| Q2 2016 | $1,156,000 | -3.1% | 7,940 | -4.7% | 0.01% | -11.1% |
| Q1 2016 | $1,193,000 | -1.0% | 8,330 | +6.8% | 0.01% | 0.0% |
| Q4 2015 | $1,205,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |